Emerging Threat Intelligence™ Program

Are you interested in accessing real-time information on current drug use trends in the U.S.?

Millennium Health’s Emerging Threat Intelligence (ETI) Program provides timely surveillance data to help identify dangerous drug use patterns and support overdose prevention activities.

How it Works

We monitor real-time trends in drug use utilizing over 15 million definitive urine drug test (UDT) results from over 4 million patients representing all 50 states across multiple healthcare specialties (substance use disorder (SUD) treatment, behavioral health, primary care, pain management, OB-GYN).

This powerful resource can be used to:

Investigate specific research questions
Curate timely national, regional and state-specific reports
Provide access to a near-real-time data stream

The ETI Program in Action

Our research has been published in numerous peer-reviewed publications including JAMA, Drug and Alcohol Dependence, and Journal of Addiction Medicine. This program has led to collaborations with national, regional, and state public health authorities and policymakers as well as academic institutions working to better understand drug use trends and stem the overdose epidemic.

Our Collaborations Include:

U.S. Department of Health and Human Services (HHS)
Centers for Disease Control and Prevention (CDC)
Ohio Department of Public Safety
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
HEALing Communities Study
The Ohio State University
University of Cincinnati
Johns Hopkins Bloomberg School of Public Health
Montana Department of Health and Human Services
University of Colorado School of Medicine

“Timely drug testing data allows us to rapidly assess drug use patterns, regional differences in drug use, emerging threats, and determine whether prescription drugs are being misused. Access to such allows for an improved ability to tailor prevention and response efforts.”

Grant Baldwin, PhD, MPH
Director of the Division of Overdose Prevention, CDC

“The findings also demonstrate that aggregated, quantitative UDT data offer a scalable surveillance method that can provide swift and nimble feedback on real-time changes in drug exposure levels as well as emerging threats, like xylazine, that are not routinely captured by other methods.”

Andrew Huhn, PhD, MBA
Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine

“Millennium Health’s [data] will help the community coalitions in HCS to use data to inform their implementation strategies to reduce overdose deaths.”

Nabila El-Bassel, PhD
Director, Social Intervention Group, Columbia University
and Principal Investigator for the New York Research Site of HEALing Community Study (HCS)

About Our Team

The Emerging Threat Intelligence Program would not be possible without the dedicated efforts and expertise of our unparalleled Clinical Affairs and Business Technology teams working together to analyze de-identified drug test results to monitor real-time drug use trends across the country.

Learn More About Our Team